Fiad T M, Duffy J, McKenna T J
Department of Endocrinology, St Vincent's Hospital, Dublin, Ireland.
Clin Endocrinol (Oxf). 1994 Sep;41(3):391-5. doi: 10.1111/j.1365-2265.1994.tb02563.x.
A 57-year-old man with a history of liver fibrosis, portal hypertension and hypersplenism had thyroid function assessed because of weight loss. Free T4 (FT4), total T4 (TT4), total T3 (TT3) and TSH were all assayed by enhanced chemiluminescent immunoassay. This demonstrated elevation of all three hormones. Because of the atypical profile obtained and because the patient appeared to be euthyroid, re-assay of the patient's serum was performed following immunoglobulin precipitation with 50% polyethylene glycol. The levels of T4 and T3 were then found to be within the reference ranges suggesting that the serum contained interfering immunoglobulins. Anti-immunoglobulin antibodies also neutralized the interfering substances present in the patient's serum. These observations indicate that non-specific immunoglobulins present in the patient's serum cross-reacted with the antibodies employed in the assays used, giving rise to spurious results. To our knowledge, this is the first report of artefactual elevation of results obtained by T4, T3 and TSH assays of a serum occurring as a result of interfering immunoglobulins. Their presence became apparent only because of the very rare coincidence of antibodies interfering with more than one assay giving rise to an atypical hormone pattern. The frequency of this phenomenon affecting a single assay and therefore more likely to go undetected, is unknown and is a cause for concern.
一名57岁男性,有肝纤维化、门静脉高压和脾功能亢进病史,因体重减轻接受甲状腺功能评估。游离甲状腺素(FT4)、总甲状腺素(TT4)、总三碘甲状腺原氨酸(TT3)和促甲状腺激素(TSH)均采用增强化学发光免疫分析法检测。结果显示这三种激素均升高。由于检测结果异常且患者甲状腺功能看似正常,因此在用50%聚乙二醇进行免疫球蛋白沉淀后,对患者血清进行了重新检测。随后发现T4和T3水平在参考范围内,提示血清中含有干扰性免疫球蛋白。抗免疫球蛋白抗体也中和了患者血清中存在的干扰物质。这些观察结果表明,患者血清中存在的非特异性免疫球蛋白与检测所用的抗体发生交叉反应,导致了假结果。据我们所知,这是关于因干扰性免疫球蛋白导致血清T4、T3和TSH检测结果出现人为升高的首次报告。仅因抗体干扰多种检测导致非典型激素模式这一非常罕见的巧合,它们的存在才变得明显。这种影响单一检测且因此更可能未被发现的现象的发生频率尚不清楚,令人担忧。